C.I. MedicalLtd Performance dei guadagni passati

Il passato criteri di controllo 5/6

C.I. MedicalLtd ha registrato una crescita degli utili a un tasso medio annuo di 6.4%, mentre il settore Healthcare ha registrato utili in crescita a un tasso medio annuo di 6.7%. I ricavi sono stati in crescita a un tasso medio annuo di 10.4%. Il ritorno sul capitale proprio di C.I. MedicalLtd è 22.7% e ha margini netti di 9.9%.

Informazioni chiave

6.4%

Tasso di crescita degli utili

6.4%

Tasso di crescita dell'EPS

Healthcare Crescita del settore	7.9%
Tasso di crescita dei ricavi	10.4%
Rendimento del capitale proprio	22.7%
Margine netto	9.9%
Ultimo aggiornamento sui guadagni	30 Sep 2024

Aggiornamenti sulle prestazioni recenti

Recent updates

Introducing C.I. MedicalLtd (TYO:3540), The Stock That Zoomed 114% In The Last Year

Feb 18

Should You Be Adding C.I. MedicalLtd (TYO:3540) To Your Watchlist Today?

Jan 31

Can C.I. MedicalLtd (TYO:3540) Keep Up These Impressive Returns?

Jan 13

Could The Market Be Wrong About C.I. Medical Co.,Ltd. (TYO:3540) Given Its Attractive Financial Prospects?

Dec 26

Is C.I. Medical Co.,Ltd. (TYO:3540) Potentially Undervalued?

Dec 08

Can You Imagine How Jubilant C.I. MedicalLtd's (TYO:3540) Shareholders Feel About Its 118% Share Price Gain?

Nov 20

Ripartizione dei ricavi e delle spese

Come C.I. MedicalLtd guadagna e spende denaro. In base agli ultimi utili dichiarati, su base LTM.

Storia dei guadagni e delle entrate

TSE:3540 Ricavi, spese e utili (JPY Millions )
Data	Ricavi	Guadagni	Spese G+A
30 Sep 24	57,228	5,680	14,852
30 Jun 24	47,747	1,433	10,081
31 Mar 24	46,575	1,808	9,562
31 Dec 23	45,628	2,082	9,004
30 Sep 23	45,071	2,162	8,452
30 Jun 23	44,125	2,219	8,132
31 Mar 23	43,473	2,173	7,931
31 Dec 22	42,891	2,521	7,681
30 Sep 22	42,073	2,709	7,533
30 Jun 22	41,754	2,798	7,358
31 Mar 22	41,142	2,815	7,242
31 Dec 21	41,205	2,820	7,081
30 Sep 21	41,500	3,182	7,041
30 Jun 21	40,833	3,334	6,872
31 Mar 21	39,593	3,309	6,622
31 Dec 20	37,393	2,920	6,590
30 Sep 20	33,251	2,263	6,260
30 Jun 20	31,964	1,924	6,093
31 Mar 20	30,265	1,608	5,959
31 Dec 19	28,763	1,505	5,653
30 Sep 19	28,876	1,571	5,475
30 Jun 19	26,898	1,345	5,268
31 Mar 19	26,484	1,414	5,112
31 Dec 18	25,806	1,329	4,945
30 Sep 18	24,892	1,358	4,757
30 Jun 18	24,323	1,458	4,523
31 Mar 18	23,336	1,445	4,263
31 Dec 17	22,830	1,539	4,088
30 Sep 17	21,999	1,486	3,932
30 Jun 17	21,440	1,497	3,881
31 Mar 17	20,887	1,390	3,794
31 Dec 16	20,334	1,282	3,706
31 Dec 15	18,145	1,088	3,079
31 Dec 14	16,084	901	2,712

Guadagni di qualità: 3540 ha un grande una tantum guadagno di ¥4.6B che ha avuto un impatto sui suoi ultimi 12 mesi di risultati finanziari pari a 30th September, 2024.

Margine di profitto in crescita: Gli attuali margini di profitto netti di 3540 (9.9%) 3540 sono più alti rispetto allo scorso anno (4.8%).

Flusso di cassa libero e analisi degli utili

Analisi della crescita degli utili nel passato

Andamento degli utili: Gli utili di 3540 sono cresciuti del 6.4% all'anno negli ultimi 5 anni.

Accelerare la crescita: La crescita degli utili di 3540 nell'ultimo anno ( 162.7% ) supera la media quinquennale ( 6.4% all'anno).

Guadagni vs Settore: La crescita degli utili 3540 nell'ultimo anno ( 162.7% ) ha superato la percentuale del settore Healthcare 5.1%.

C.I. MedicalLtd Performance dei guadagni passati

Il passato criteri di controllo 5/6

Informazioni chiave

Aggiornamenti sulle prestazioni recenti

Third quarter 2024 earnings released: EPS: JP¥95.20 (vs JP¥10.26 in 3Q 2023)

Second quarter 2024 earnings released

C.I. Medical Co.,Ltd. to Report Q2, 2024 Results on Aug 13, 2024

First quarter 2024 earnings released: EPS: JP¥24.70 (vs JP¥52.11 in 1Q 2023)

Full year 2023 earnings released: EPS: JP¥208 (vs JP¥252 in FY 2022)

C.I. Medical Co.,Ltd. to Report Fiscal Year 2023 Results on Feb 13, 2024

Recent updates

Investor sentiment deteriorates as stock falls 17%

New major risk - Revenue and earnings growth

Third quarter 2024 earnings released: EPS: JP¥95.20 (vs JP¥10.26 in 3Q 2023)

C.I. MedicalLtd (TSE:3540) Has A Somewhat Strained Balance Sheet

New minor risk - Profit margin trend

Second quarter 2024 earnings released

C.I. Medical Co.,Ltd. (TSE:3540) Looks Just Right With A 25% Price Jump

Investor sentiment improves as stock rises 36%

New minor risk - Share price stability

New minor risk - Dividend sustainability

Investor sentiment improves as stock rises 20%

C.I. Medical Co.,Ltd. to Report Q2, 2024 Results on Aug 13, 2024

First quarter 2024 earnings released: EPS: JP¥24.70 (vs JP¥52.11 in 1Q 2023)

C.I. Medical Co.,Ltd. (TSE:3540) signed sale and purchase agreement to acquire Nissen Holdings Co., Ltd. from Seven & i Net Media Co., Ltd. for ¥4.1 billion.

C.I. Medical Co.,Ltd. (TSE:3540) signed sale and purchase agreement to acquire Nissen Holdings Co., Ltd. from Seven & i Net Media Co., Ltd. for ¥4.1 billion.

C.I. Medical Co.,Ltd., Annual General Meeting, Mar 26, 2024

Full year 2023 earnings released: EPS: JP¥208 (vs JP¥252 in FY 2022)

C.I. Medical Co.,Ltd. to Report Fiscal Year 2023 Results on Feb 13, 2024

Upcoming dividend of JP¥25.00 per share at 0.6% yield

Investor sentiment improves as stock rises 15%

New major risk - Financial position

Third quarter 2023 earnings released: EPS: JP¥51.29 (vs JP¥57.01 in 3Q 2022)

C.I. Medical Co.,Ltd. to Report Q3, 2023 Results on Nov 14, 2023

New major risk - Earnings quality

Second quarter 2023 earnings released: EPS: JP¥70.50 (vs JP¥65.91 in 2Q 2022)

C.I. Medical Co.,Ltd. to Report Q2, 2023 Results on Aug 08, 2023

First quarter 2023 earnings released: EPS: JP¥52.10 (vs JP¥86.91 in 1Q 2022)

Full year 2022 earnings: EPS misses analyst expectations

Now 23% undervalued after recent price drop

Consensus EPS estimates fall by 16%, revenue upgraded

Full year 2022 earnings: EPS misses analyst expectations

C.I. Medical Co.,Ltd. to Report Fiscal Year 2022 Results on Feb 14, 2023

Upcoming dividend of JP¥28.50 per share

Third quarter 2022 earnings released: EPS: JP¥57.01 (vs JP¥65.91 in 3Q 2021)

Third quarter 2022 earnings released: EPS: JP¥56.99 (vs JP¥65.91 in 3Q 2021)

C.I. Medical Co.,Ltd. (TSE:3540) agreed to acquire Naiki Shiken Ltd. from Yuichi Naiki and Yuriko Naiki.

C.I. Medical Co.,Ltd. to Report Q3, 2022 Results on Nov 08, 2022

C.I. Medical Co.,Ltd. (TSE:3540) agreed to acquire Sakura Dental Laboratory from Akira Ochi and Katsumi Ochi.

Second quarter 2022 earnings released: EPS: JP¥65.90 (vs JP¥67.61 in 2Q 2021)

C.I. Medical Co.,Ltd. to Report Q2, 2022 Results on Aug 09, 2022

First quarter 2022 earnings: EPS misses analyst expectations

Price target decreased to JP¥4,300

C.I. Medical Co.,Ltd. to Report Q1, 2022 Results on May 10, 2022

Investor sentiment improved over the past week

C.I. Medical Co.,Ltd., Annual General Meeting, Mar 24, 2022

Full year 2021 earnings: EPS misses analyst expectations

Now 22% undervalued after recent price drop

Now 20% undervalued after recent price drop

Price target decreased to JP¥5,300

Third quarter 2021 earnings released: EPS JP¥65.89 (vs JP¥81.10 in 3Q 2020)

Second quarter 2021 earnings released: EPS JP¥67.61 (vs JP¥65.10 in 2Q 2020)

Investor sentiment deteriorated over the past week

Looop Inc. agreed to acquire 60% stake in Niigata Prefectural Electric Power Co., Ltd. and Yotsuba Electric Power Co., Ltd. from C.I. Medical Co.,Ltd. (JASDAQ:3540).

Investor sentiment improved over the past week

First quarter 2021 earnings released: EPS JP¥87.40 (vs JP¥48.50 in 1Q 2020)

Here's Why We Think C.I. MedicalLtd (TYO:3540) Is Well Worth Watching

Returns on Capital Paint A Bright Future For C.I. MedicalLtd (TYO:3540)

Full year 2020 earnings released: EPS JP¥292 (vs JP¥151 in FY 2019)

Investor sentiment improved over the past week

Should You Investigate C.I. Medical Co.,Ltd. (TYO:3540) At JP¥5,450?

New 90-day low: JP¥5,490

Analysts increase EPS estimates to JP¥320

Introducing C.I. MedicalLtd (TYO:3540), The Stock That Zoomed 114% In The Last Year

C.I. Medical Co.,Ltd. (JASDAQ:3540) acquired 22.4% stake in Fuji Dental Lab Co., Ltd.

Full year 2020 earnings released: EPS JP¥292 (vs JP¥151 in FY 2019)

Revenue and earnings beat expectations

Should You Be Adding C.I. MedicalLtd (TYO:3540) To Your Watchlist Today?

Yosuke Oda Kaki and Keisuke Hori agreed to acquire an additional 60% stake in One Recto Holdings Co., Ltd. from C.I. Medical Co.,Ltd. (JASDAQ:3540).

New 90-day low: JP¥5,900